EP1228081A1 - Elektrochemische detektion von sequenzspezifischen nukleinsäure-oligomer-hybridisierungsereignissen - Google Patents
Elektrochemische detektion von sequenzspezifischen nukleinsäure-oligomer-hybridisierungsereignissenInfo
- Publication number
- EP1228081A1 EP1228081A1 EP00972570A EP00972570A EP1228081A1 EP 1228081 A1 EP1228081 A1 EP 1228081A1 EP 00972570 A EP00972570 A EP 00972570A EP 00972570 A EP00972570 A EP 00972570A EP 1228081 A1 EP1228081 A1 EP 1228081A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleic acid
- redox
- catalytically
- modified
- acid oligomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
Definitions
- the present invention relates to a modified nucleic acid oligomer and a method for the electrochemical detection of sequence-specific nucleic acid oligomer hybridization events.
- RNA and DNA For sequence analysis of DNA and RNA, e.g. B. in disease diagnosis, in toxicological test methods, in genetic research and development, and in the agricultural and pharmaceutical sector, gel electrophoretic methods with autoradiographic or optical detection are generally used.
- each reaction mixture contains enough 2 ', 3'-dideoxy analogue of one of these nucleoside triphosphates as a stop base (one of each 4 possible stop bases per approach) to stop replication at all possible binding sites.
- Another optical detection method is based on the attachment of fluorescent dyes such.
- 32 P is incorporated into the phosphate skeleton of the oligonucleotides, 32 P usually being added at the 5'-hydroxyl end by polynucleotide kinase.
- the labeled DNA is then preferably cleaved on one of the four nucleotide types, under defined conditions, so that an average cleavage occurs per chain.
- connection is made in an ordered grid of 65536 test sites, a larger amount of an oligonucleotide combination defining a test site and the position of each individual test site (oligonucleotide combination) being known.
- the oligomer chip a DNA fragment, the sequence of which is to be determined (the target), is labeled with fluorescent dye (or 32 P) and hybridized under conditions which only permit specific double-strand formation.
- the target DNA fragment only binds to the nucleic acid oligomers (in the example to the octamers) whose complementary sequence corresponds exactly to a part (an octamer) of its own sequence.
- nucleic acid oligomer sequences By optical (or autoradiographic) detection of the binding position of the hybridized DNA fragment, all nucleic acid oligomer sequences (octamer sequences) present in the fragment are thus determined. Due to the overlap of neighboring nucleic acid oligomer sequences, the continuous sequence of the DNA fragment can be determined by suitable mathematical algorithms. The advantages of this method include the miniaturization of the sequencing and thus the enormous amount of data that is recorded simultaneously in one operation. In addition, primers and the gel electrophoretic separation of the DNA fragments can be dispensed with. This principle is shown by way of example in FIG. 1 for a 13 base long DNA fragment.
- oligonucleotide sequences or DNA fragments which code one or more known genes can also be bound on the oligomer chip described above. So z. B. for each gene of known base sequence searched a sufficient number of oligonucleotide sequences from z. B. 20 bases each, which are complementary to corresponding sequence sections of the gene sought with a known base sequence, are applied to a support material in order to detect this gene with a very high probability. On the other hand, known genes can also be tested for mutations on an oligomer chip, for example by B. the corresponding sequence segments of the genes with and without mutation can be applied to the carrier material.
- radioactive labels in DNA / RNA sequencing has several disadvantages, such as e.g. B. complex, legally prescribed safety precautions when handling radioactive materials, the radiation exposure, the limited spatial resolution (maximum 1mm 2 ) and a sensitivity that is only high if the radiation of the radioactive fragments for a correspondingly long (hours to days) X-ray film acts.
- the spatial resolution can be increased by additional hardware and software and the detection time can be shortened by using ⁇ scanners, both are associated with considerable additional costs.
- the fluorescent dyes which are usually used to label the DNA, are partly mutagenic (e.g. ethidium bromide) and, like the use of autoradiography, require corresponding safety precautions.
- the use of optical detection requires the use of one or more laser systems and thus trained personnel and appropriate safety precautions.
- the actual detection of fluorescence requires additional hardware, such as. B. optical components for amplification and, at different excitation and interrogation wavelengths as in the Sanger process, a control system. Depending on the required excitation wavelengths and the desired detection power, considerable investment costs can arise.
- the detection is even more (expensive) because, in addition to the excitation system, high-resolution CCD cameras (charge coupled device cameras) are required for the 2-dimensional detection of the fluorescence spots.
- the object of the present invention is therefore to create a device and a method for the detection of nucleic acid-oligomer hybrids which do not have the disadvantages of the prior art.
- modified nucleic acid oligomer according to independent patent claim 1 by the method for producing a modified nucleic acid oligomer according to independent claim 22, by the modified conductive surface according to independent patent claim 34, by the method for producing a modified conductive surface according to independent patent claim 34 Claim 49 and a method for the electrochemical detection of nucleic acid-oligomer hybridization events according to independent claim 53.
- PNA Peptide nucleic acid synthetic DNA or RNA in which the sugar-phosphate unit is replaced by an amino acid.
- synthetic DNA or RNA synthetic DNA or RNA in which the sugar-phosphate unit is replaced by an amino acid.
- sugar-phosphate unit is replaced by the -NH- (CH 2 ) 2 - N (COCH 2 base) -CH 2 CO - Unit hybridizes PNA with DNA.
- Nucleic acid at least two covalently linked nucleotides or at least two covalently linked pyrimidine (e.g. cytosine, thymine or uracil) or purine bases (e.g. adenine or guanine).
- the term nucleic acid refers to any "backbone" of the covalently linked pyrimidine or purine bases, such as. B. on the sugar-phosphate backbone of the DNA, cDNA or RNA, on a peptide backbone of the PNA or on analogous structures (e.g. phosphoramide, thio-phosphate or dithio-phosphate backbone).
- An essential feature of a nucleic acid in the sense of the present invention is that it can bind naturally occurring cDNA or RNA in a sequence-specific manner.
- Nucleic acid - nucleic acid of unspecified base length e.g. oligomeric nucleic acid octamer: a nucleic acid with any backbone in which 8 pyrimidine or purine bases are covalently bonded to one another.
- Oligomer equivalent to nucleic acid oligomer Oligomer equivalent to nucleic acid oligomer.
- Oligonucleotide equivalent to oligomer or nucleic acid oligomer e.g. B. a DNA, PNA or RNA fragment unspecified base length.
- Oligo Abbreviation for oligonucleotide Oligo Abbreviation for oligonucleotide.
- Primer start complementary fragment of an oligonucleotide the base length of the primer being only about 4-8 bases. Serves as a starting point for the enzymatic replication of the oligonucleotide.
- the two single strands hybridize in such a way that the base A (or C) of one strand forms hydrogen bonds with the base T (or G) of the other strand (in RNA, T is replaced by uracil) , Any other base pairing does not form hydrogen bonds, distorts the structure and is referred to as a "mismatch".
- SS Single Strand ds double Strand redox-active unit corresponds to a catalytically redox-active unit catalytically a unit referred to in the context of the present invention under the redox-active unit generic term "catalytically redox-active unit” consists of one or more redox-active centers (cofactors, prosthetic groups), hereinafter referred to as electron donors or electron acceptors, and one or more macromolecules binding these redox-active centers.
- redox-active unit consists of one or more redox-active centers (cofactors, prosthetic groups), hereinafter referred to as electron donors or electron acceptors, and one or more macromolecules binding these redox-active centers.
- the catalytically redox-active unit thus contains one or more electron-donor molecules and / or one or more electron-acceptor molecules in their appearance-relevant form, whereby this electron-donor molecule (s) and / or this (these) Electron acceptor molecule (s) is / is bound to one or more macromolecules or is embedded in this (s) macromolecule (s).
- Electron donor (s) and / or electron acceptor (s) can be mutually linked by one or more covalent or ionic bonds, by hydrogen bonds, by van der Waals bridges, by ⁇ - ⁇ interaction or by coordination be connected to one another by means of electron pair donation and acceptance, it being possible for covalent compounds to be direct or indirect (eg via a spacer but not via a nucleic acid oligomer) compounds.
- the electron donor (s) and / or electron acceptor (s) with the macromolecule (s) by covalent attachment to the macromolecule (s), by encapsulation in suitable molecular cavities (binding pockets) of the Macromolecule (of the macromolecules), by ionic bonds, hydrogen bonds, van der Waals bridges, ⁇ - ⁇ interaction or by coordination by means of electron pair donation and acceptance between the macromolecule (s) and the (n) electron donor molecule (s) and / or the electron acceptor molecule (s).
- a catalytically redox-active unit can also consist of only one macromolecule, the macromolecule then also acting as an electron donor or acceptor in its manifestation relevant to the invention. It can also consist of only one electron donor or acceptor.
- the catalytically redox-active unit can also be formed by spontaneously assembling the component in solution (in situ).
- the unit is in the manifestations relevant to the invention (electron donor (s) and / or electron acceptor (s) in the original or oxidized or reduced state) stable and does not dissociate into its components, (ii) the electrocatalytic activity of the unit (see below), (iii) the unit contains no nucleic acid, (iv)
- the composition of the unit consisting of electron donor (s) and / or electron acceptor (s) and / or macromolecule (s) can be recognized by a person skilled in the art - regardless of the bond between the components - since the redox-active centers (cofactors, prosthetic Groups) and the associated matrix of macromolecule (s) (e.g.
- the catalytically redox-active unit can, for. B. any redox-active protein / enzyme from the group of oxidases or reductases, proteins / enzymes from this group of oxidases or reductases modified by protein engineering or gene mutation or an artificially produced unit from one or more redox-active centers (electron donor or . Acceptor) or an artificially produced unit from one or more redox-active centers (electron donor or acceptor) and one or more macromolecules binding these redox-active centers.
- Cofactor corresponds to a redox-active center (electron donor or acceptor) of the catalytically redox-active unit prosthetic group corresponds to a redox-active center (electron donor or acceptor) of the catalytically redox-active unit, the redox-active center, the redox-active center of the catalytically redox-active unit, the center, which is distinguished by the fact that it acts as a redox-active unit as a redox-active unit compared to a substrate specific for the catalytically, Donor or acceptor acts.
- a charge transfer can also occur within the catalytically redox-active unit: after the charge transfer there is between the substrate specific for the catalytically redox-active unit and a first redox-active center a further charge transfer between this first redox-active center and a further redox-active center of the same catalytically redox-active unit is possible, this second redox-active center in turn being able to transfer charge to a third redox-active center, etc.
- Electron donor- corresponds to an electron donor. molecule
- Elekron acceptor corresponds to an electron acceptor. molecule
- Electron donor in the context of the present invention, denotes a component of the catalytically redox-active unit.
- An electron donor is a molecule that can transfer an electron to an electron acceptor immediately or after exposure to certain external circumstances. Such an external circumstance is e.g. B. the oxidation or reduction of the electron donor or - acceptor of the catalytically redox-active unit by a external oxidizing or reducing agent, so z. B. the transfer of an electron to the electron donor by a reducing agent or the release of an electron by the electron acceptor to an oxidizing agent.
- oxidizing or reducing agents can be external redox-active substances, ie they are not covalently linked to the catalytically redox-active unit, the nucleic acid oligomer or the conductive surface, but are associated with these, e.g. B. via the solution added to the modified conductive surface, in contact, in particular the substrates specific for the catalytically redox-active unit can act as external oxidizing or reducing agents.
- an external oxidizing or reducing agent can also be covalently linked to the nucleic acid oligomer, the oxidizing or reducing agent being covalently linked to a point on the nucleic acid oligomer that contains at least two covalently linked nucleotides or at least two covalently linked pyrimidine or Purine bases is removed from the covalent attachment site of the redox-active unit, preferably at the end of the oligonucleotide opposite the modification with the catalytically redox-active unit in the vicinity of the conductive surface.
- the conductive surface can also act as an external oxidizing or reducing agent.
- the ability to act as an electron donor or acceptor is relative, ie a molecule which acts as an electron donor immediately or after the action of certain external circumstances can act against this molecule under different experimental conditions or against a third molecule same or different experimental conditions also act as an electron acceptor.
- Electron acceptor in the context of the present invention, denotes a component of a catalytically redox-active unit.
- An electron acceptor is a molecule that can accept an electron from an electron donor immediately or after exposure to certain external circumstances. Such an outside Circumstance is z. B. the oxidation or reduction of the electron donor or acceptor of the catalytically redox-active unit by an external oxidizing or reducing agent, so z. B. the transfer of an electron to the electron donor by a reducing agent or the release of an electron by the electron acceptor to an oxidizing agent.
- oxidizing or reducing agents can be external redox-active substances, ie they are not covalently linked to the catalytically redox-active unit, the nucleic acid oligomer or the conductive surface, but are associated with these, e.g. B. via the solution added to the modified conductive surface, in contact, in particular the substrates specific for the catalytically redox-active unit can act as external oxidizing or reducing agents.
- an external oxidizing or reducing agent can also be covalently linked to the nucleic acid oligomer, the oxidizing or reducing agent being covalently linked to a point on the nucleic acid oligomer that contains at least two covalently linked nucleotides or at least two covalently linked pyrimidine or Purine bases is removed from the covalent attachment site of the catalytically redox-active unit, preferably at the end of the oligonucleotide opposite the modification with the redox-active unit in the vicinity of the conductive surface.
- the conductive surface (electrode) can also act as an external oxidizing or reducing agent.
- the ability to act as an electron acceptor or donor is relative, ie a molecule which acts as an electron acceptor immediately or after the action of certain external circumstances can act against this molecule under different experimental conditions or against a third molecule same or different experimental conditions also act as an electron donor.
- Oxidizing agent chemical compound which by taking up electrons from another chemical compound (chemical substance, electron donor, electron acceptor) this other chemical compound (chemical Substance, electron donor, electron acceptor) oxidized.
- An oxidizing agent behaves analogously to an electron acceptor, but is used in the context of the present invention as a term for an external electron acceptor that does not directly belong to the catalytically redox-active unit. In this context, not directly means that the oxidizing agent is either a substrate specific for the catalytically redox-active unit or a free redox-active substance which is not bound to the nucleic acid oligomer but is in contact with it.
- the oxidizing agent can be covalently linked to the nucleic acid oligomer, but at a point on the nucleic acid oligomer that is at least two covalently linked nucleotides or at least two covalently linked pyrimidine or purine bases from the covalent linkage point of the catalytically redox-active unit.
- the electrode can also be the oxidizing agent.
- Reducing agent chemical compound which, by donating electrons to another chemical compound (chemical substance, electron donor, electron acceptor), reduces this other chemical compound (chemical substance, electron donor, electron acceptor).
- a reducing agent behaves analogously to an electron donor, but is used in the context of the present invention as a term for an external electron donor that does not directly belong to the catalytically redox-active unit.
- the reducing agent is either a substrate specific for the catalytically redox-active unit or a free redox-active substance which is not bound to the nucleic acid oligomer but is in contact therewith or that the reducing agent is covalently to the nucleic acid -
- the oligomer is attached, but at a point on the nucleic acid oligomer which is at least two covalently linked nucleotides or at least two covalently linked pyrimidine or purine bases from the covalent linkage site of the redox-active unit.
- the electrode can also represent the reducing agent.
- redox active redox active denotes the property of a redox active unit to give electrons to a suitable oxidizing agent under certain external circumstances or to take up electrons from a suitable reducing agent or the property of a redox active substance to give electrons to a suitable electron acceptor under certain external circumstances or from a suitable electron To accept donor electrons.
- Analyte corresponds to a substrate
- Substrate free, not covalently with the catalytically redox-active unit, the nucleic acid oligomer or the conductive surface composite, but with these, e.g. B. on the modified conductive surface added solution, contacting oxidizing or reducing agent, the substrate z. B. can be a charged or uncharged molecule, any salt, an ion or a redox-active protein or enzyme (oxidoreductase).
- the substrate is characterized in that it is recognized by the catalytically redox-active unit through the formation of specific interactions between the substrate and the catalytically redox-active unit and can reduce (or oxidize) the donor (or the acceptor) of the catalytically redox-active unit, the catalytic Activity of the catalytically redox-active unit accelerates (catalyzes) this redox reaction of the substrate to the product.
- Catalytic activity The catalytic activity of the catalytically redox-active unit has an accelerating effect on the specific reaction between the unit and the associated substrate and thus enables a reaction sequence which does not take place or only to an imperceptible extent without the catalytic activity of the unit.
- This catalytic activity of the redox-active unit is achieved by stabilizing the respective transition state, ie the most energetic species, in the course of the reaction between the catalytically redox-active unit and the associated substrate.
- electrocatalytic the electrocatalytic activity of the catalytic redox active activity is closely related to the catalytic activity of the Unit.
- the electro-chemical conversion of the substrate at the electrode is accelerated.
- the electrocatalytic activity of a catalytically redox-active unit immobilized on an electrode reduces the activation energy of the electrode reaction of the substrate to the product (energy of the most energetic state for the reaction sequence of the conversion of the substrate into the product at the electrode) and thereby leads to a shift in the for the electrode reaction of the Substrate to the product necessary electrode potential in the direction of the equilibrium potential for these electrodes reaction.
- the lowering of the activation potential leads to a reduction in the overvoltage necessary for an electrode reaction and thus to an increase in the electron foot between the electrode and the substrate at a certain electrode potential suitable for the electrode reaction (this increase is generally referred to as catalytic current).
- the main consequence of the electrocatalytic activity is that the electrochemical conversion of the substrate into the product can be carried out in the presence and with the participation of the catalytically redox-active unit at an electrode potential at which no or only very little current flows in the absence of the catalytically redox-active unit.
- the specificity of the catalytically redox-active unit acts specifically both with regard to the catalytically active redox-active unit substrate interacting with the catalytically redox-active unit and with regard to the reaction carried out with the respective substrate.
- redox reactions are the preferred reactions between catalytically redox-active unit and substrate. Initiation process with appropriately chosen external circumstances, the catalytically redox-active unit unfolds its redox activity, ie its property, e.g. B. to give electrons to a suitable oxidizing agent or to take up electrons from a suitable reducing agent, only after an initiation process.
- Such an initiation process can be the transfer of substrate with its property charge to the catalytically redox-active unit:
- the reductive property of a catalytically redox-active unit is only through the transfer of electron (s) from the substrate to / an electron donor "D "enables, either in the presence of an oxidizing agent that can oxidize D " but not D, or because after successive charge transfer within the catalytically redox-active unit, the electron is transferred from D ⁇ to an acceptor "A" (directly or via several electron transfer steps to intermediate Electron acceptors) and an oxidizing agent is present which only accepts electrons from this reduced acceptor "A ⁇ " of the catalytically redox-active unit, but not from A.
- this oxidizing agent can also be an electrode, for example if the electrode is on an Potential is set at which D " (or A " ), but not D (or A), ox is identified.
- the oxidative property of a catalytically redox-active unit is only made possible by the transfer of electron (s) from an electron donor "D" to the substrate, either in the presence of a reducing agent that can reduce D + but not D or because after successive charge transfer within the catalytically redox-active unit, an electron is transferred from an acceptor "A” to the oxidized donor D + (directly or via several electron transfer steps of intermediate electron donors) and a reducing agent is present which is only present on this oxidized acceptor "A + " catalytically redox-active unit emits electrons, but not to A.
- this reducing agent can also be an electrode, for. B. if the electrode is set to a potential at which D + (or A + ), but not D (or A), is reduced.
- Redox active usually consists of so-called apoprotein, which (the) (Formula 3)
- alkyl denotes a saturated hydrocarbon group that is straight-chain or branched (eg ethyl, 2,5-dimethylhexyl or isopropyl etc.).
- alkyl refers to a group with two available valences for covalent linkage (e.g. -CH 2 CH 2 -, -CH 2 C (CH 3 ) 2 CH 2 CH 2 C (CH 3 ) 2 CH 2 - or -CH 2 CH 2 CH 2 - etc.).
- Preferred alkyl groups as substituents or side chains R are those of chain length 1-30 (longest continuous chain of atoms covalently bonded to one another).
- Preferred alkyl groups as linkers or spacers are those of chain length 1-20, in particular chain length 1-14, the chain length here being the shortest continuous connection between the structures connected by the linker or spacer, that is to say between the two molecules or between a surface atom, Surface molecule or a surface molecule group and another molecule.
- Alkynyl alkyl or alkenyl groups in which one or more of the CC single or C C double bonds by C ⁇ C Triple bonds are replaced.
- linkers are commercially available as alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl chains, the chain being derivatized at two points with (identical or different) reactive groups. These groups form a covalent chemical bond in simple / known chemical reactions with the corresponding reaction partners.
- the reactive groups can also be photoactivatable, i. H. the reactive groups are only activated by light of certain or any wavelength.
- Preferred linkers are those of chain length 1-20, in particular chain length 1-14, the chain length here being the shortest continuous connection between the structures to be connected, i.e. between the two molecules or between a surface atom, surface molecule or a surface molecule group and another molecule , represents.
- Spacer linker which is covalently bonded via the reactive groups to one or both of the structures to be connected (see linker).
- Preferred spacers are those of chain length 1-20, in particular chain length 1-14, the chain length being the shortest continuous connection between the structures to be connected.
- These spacers can in turn be bound to various reactive groups that are naturally present on the nucleic acid oligomer or are attached to it by modification and “n” is any integer, in particular a number between 1 and 20.
- n x R-S-S spacer Nucleic acid oligomer to which n disulfide functions are each connected via a spacer via oligo, any residue R saturating the disulfide function.
- the spacer for connecting the disulfide function to the nucleic acid oligomer can each have a different chain length (shortest continuous connection between the disulfide function and nucleic acid oligomer), in particular any chain length between 1 and 14. These spacers can in turn be connected to various naturally on the nucleic acid Oligomeric reactive groups attached or attached to this by modification.
- the placeholder n is any integer, in particular a number between 1 and 20.
- Oligo-Spacer-SS- two identical or different nucleic acid oligomers that are connected to each other via a disulfide bridge, the disulfide bridge being connected to the nucleic acid oligomers via any two spacers and the two spacers having a different chain length (shortest can have a continuous connection between the disulfide bridge and the respective nucleic acid oligomer), in particular any chain length between 1 and 14, and these spacers can in turn be bound to various reactive groups that are naturally present on the nucleic acid oligomer or are attached to them by modification.
- mice Mica muscovite platelets, carrier material for thin application Layers.
- the terminal phosphate group of the oligonucleotide is esterified at the 3 'end with (HO- (CH 2 ) 2 -S) 2 to PO- (CH 2 ) 2 -SS- (CH 2 ) 2 -OH, the SS bond being cleaved homolytically and each causes an Au-SR bond.
- FAD is bound via amide formation, which was previously modified so that it has a reactive amino group, e.g. B. by formation of N 6 - (2-aminoethyl) -FAD (Bückmann et al, 1991, European Patent 0.247.537. B1).
- the FAD is then reconstituted with the apoprotein of the GOx, so that a nucleic acid oligomer covalently attached to the surface is formed, which is additionally - via PQQ as a covalently attached bridge molecule - covalently modified with the complete GOx unit.
- Au-S- ⁇ CHd ⁇ -ds-oligo-Au-S-fCH ⁇ ss-oligo-spacer-PQQ-FADfGOx hybridizes with spacer-PQQ-dem to ss-oligo (sequence: TAGTCGGAAGCA) FAD (GOx) complementary oligonucleotide.
- the terminal phosphate group of the oligonucleotide is esterified at the 3 'end with (HO- (CH 2 ) 2 -S) 2 to PO- (CH 2 ) 2 -SS- (CH 2 ) 2 -OH, the SS bond being cleaved homolytically and each causes an Au-SR bond.
- NAD + is bound via amide formation, which was previously modified so that it has a reactive amino group, e.g. B. by forming N 6 - (2-Aminoethyl) -NAD + (Bückmann et al, 1991, European Patent 0.247.537.B1). The complete LDH is associated with this terminal NAD + .
- Electrode reaction Redox reaction between a redox-active substance and an electrode absorption of electrons from the electrode by the redox-active substance or release of electrons from the redox-active substance to the electrode
- Cyclic voltammetry Recording a current / voltage curve.
- the potential of a stationary working electrode is changed linearly as a function of time, starting from a potential at which no electrooxidation or reduction takes place up to a potential at which a dissolved or adsorbed species is oxidized or reduced (i.e. current flows).
- the direction of the potential feed is reversed. The behavior of the products of electrooxidation or reduction is then recorded in the return.
- Amperometry Recording a current / time curve is the potential a stationary working electrode z. B. is set by a potential jump to a potential at which the electro-oxidation or reduction of a dissolved or adsorbed species takes place and the flowing current is recorded as a function of time.
- Potentiometry Recording an electrode voltage curve depending on the z. B. the substrate consumption.
- the "zero current" potential E ° changes in the direction of the equilibrium potential.
- * Recording the potential as a function of time ( ⁇ substrate consumption) thus provides information about the hybridization state.
- the present invention relates to a nucleic acid oligomer which is modified by chemical bonding of a catalytically redox-active unit.
- the catalytically redox-active unit can, after donating an electron to an external oxidizing agent (substrate) from an external reducing agent, e.g. B. an electrode, reduced or after receiving an electron from an external reducing agent (substrate) by an external oxidizing agent, for. B. an electrode, are oxidized.
- a nucleic acid oligomer is a compound of at least two covalently linked nucleotides or of at least two covalently linked pyrimidine (e.g. cytosine, thymine or uracil) or purine bases (e.g. adenine or guanine) , preferably a DNA, RNA or PNA fragment, is used.
- the term nucleic acid refers to any "backbone" of the covalently linked pyrimidine or purine bases, such as. B. on the sugar-phosphate backbone of the DNA, cDNA or RNA, on a peptide backbone of the PNA or on analogous backbone structures, such as. B.
- nucleic acid in the sense of the present invention is that it can bind naturally occurring cDNA or RNA in a sequence-specific manner.
- nucleic acid oligomer the terms “(probe) oligonucleotide”, “nucleic acid” or “oligomer” are used.
- electrostatic acceptor or “electron acceptor molecule” and the term “electron donor” or “electron donor molecule” in the context of the present invention denotes a component (a redox-active center or a cofactor or a prosthetic group) of a catalytically redox-active unit.
- catalytically redox-active unit generally consists of one or more redox-active centers (cofactors, prosthetic groups), which are referred to below as electron donors or electron acceptors, and one or more macromolecules binding these redox-active centers.
- the catalytically redox-active unit therefore contains one or more electron-donor molecules and / or one or more electron-acceptor molecules in their appearance-relevant form, whereby this electron-donor molecule (s) and / or this (these) Electron acceptor molecule (s) are bound to one or more macromolecules or are embedded in this (s) macromolecule (s).
- Electron donors and / or electron acceptors can be linked to one another by one or more covalent or ionic bonds, by hydrogen bonds, by van der Waals bridges, by ⁇ - ⁇ interaction or by coordination by means of an electron pair - Donation and - Acceptance can be linked to one another, where covalent compounds can be direct or indirect (eg via a spacer but not via a nucleic acid oligomer) compounds.
- the electron donor (s) and / or electron acceptor (s) with the macromolecule (s) by covalent attachment to the macromolecule (s), by encapsulation in suitable molecular cavities (binding pockets) of the Macromolecule (of the macromolecules), by ionic bonds, hydrogen bonds, van der Waals bridges, ⁇ - ⁇ interaction or by coordination by means of electron pair donation and - acceptance between the macromolecule (s) and the (n) electron donor molecule (s) and / or the electron acceptor molecule (s).
- a catalytically redox-active unit can also consist of only one macromolecule, the macromolecule then also acting as an electron donor or acceptor in its manifestation relevant to the invention. It can also consist of only one electron donor or acceptor.
- the catalytically redox-active unit can also be formed by spontaneously assembling the component in solution (in situ).
- the only restriction of the molecules or parts of molecules connecting the components of the catalytically redox-active unit is the exclusion of nucleic acid oligomers.
- the catalytically redox-active unit is bound as a complete unit to the probe oligonucleotide, it being possible, of course, to form several chemical bonds between the oligonucleotide and the redox-active unit.
- nucleic acid oligomers as the molecules or parts of molecules connecting the constituents of the catalytically redox-active unit is intended to clarify that individual parts of the catalytically redox-active unit are not linked to different locations of the probe oligonucleotide.
- the probe oligonucleotide therefore explicitly does not represent the connection between the electron donor molecule (s) and the macromolecules and / or the electron acceptor molecule (s) and the macromolecules of the catalytically redox-active unit.
- the redox activity of the catalytically redox-active unit that is to say its property, under certain external circumstances, to give off electrons to a suitable oxidizing agent (or to take up electrons from a suitable reducing agent) is initiated by an initiation process, e.g. B. only unfolded after reduction (or after oxidation) by the substrate.
- the catalytically redox-active unit only develops its redox activity after the initiation process "adding substrate with the property of transferring charge to the catalytically redox-active unit”: the reductive property of a catalytically redox-active unit is only achieved by the transfer of electrons ) from the substrate to the electron donor "D", either in the presence of an external oxidizing agent (e.g.
- the electrode with a correspondingly selected potential which can oxidize D ⁇ , but not D, or because after successive charge transfer within the catalytically redox-active unit the electron is transferred from D ⁇ to an acceptor "A" (directly or via several electron transfer steps to intermediate electron acceptors) and an oxidizing agent is present which only electrons from this reduced acceptor "A ⁇ " of the catalytically redox-active unit records " , but not from A ( e.g. in the presence of an electrode with an appropriately selected potential).
- the oxidative property of a catalytically redox-active unit is only made possible by the transfer of electron (s) from an electron donor "D" to the substrate, either in the presence of a reducing agent (e.g. the electrode with the correspondingly chosen potential), the D + , but cannot reduce D or because after successive charge transfer within the catalytically redox-active unit, an electron from an acceptor "A” to the oxidized donor D + is transferred (directly or via several electron transfer steps from intermediate electron donors) and a reducing agent is present which only gives off electrons to this oxidized acceptor "A + " of the catalytically redox-active unit, but not to A (e.g. in the presence of an electrode with correspondingly chosen potential).
- a reducing agent e.g. the electrode with the correspondingly chosen potential
- the unit is in the manifestations relevant to the invention (electron donor (s) and / or electron acceptor (s and macromolecule (s)) in the original or oxidized or reduced state) stable and does not dissociate into their components, (ii) the electrocatalytic activity of the unit (see below), (iii) the unit does not contain any Nucleic acid, (iv) the composition of the unit from electron donors) and / or electron acceptor (s) and macromolecule (s) can be recognized by the person skilled in the art - regardless of the bond between the constituents - since the redox-active centers (cofactors, prosthetic groups) and the associated matrix of macromolecule (s) (e.g. apoprotein in enzymes as an example of a catalytically redox-active unit) can in principle also occur separately.
- the substrate specific for a particular catalytically redox-active unit is a free compound that is not covalently bonded to the catalytically redox-active unit, the nucleic acid oligomer or the conductive surface, but with these, e.g. B. on the modified conductive surface added solution, contacting oxidation or
- the substrate z. B. can be a charged or uncharged molecule, any salt, an ion or a redox-active protein or enzyme (oxidoreductase).
- the substrate is characterized in that it is recognized by the catalytically redox-active unit through the formation of specific interactions between the substrate and the catalytically redox-active unit and the donor
- the (or the acceptor) of the catalytically redox-active unit can be reduced (or oxidized), the catalytic activity of the catalytically redox-active unit accelerating (catalyzing) this redox reaction of the substrate to the product.
- the catalytic activity of the catalytically redox-active unit has an accelerating effect on the specific reaction between the unit and the associated substrate and thus enables a reaction sequence which takes place without the catalytic activity of the unit (e.g. in the form of the substrate and the unbound cofactor in Solution) does not take place or only takes place to an imperceptible extent.
- This catalytic activity of the redox-active unit is achieved by stabilizing the respective transition state, ie the most energetic species in the course of the reaction between the catalytically redox-active unit and the associated substrate.
- the electrocatalytic activity of the catalytically redox-active unit is closely related to the catalytic activity of the unit.
- the electro-chemical conversion of the substrate at the electrode is accelerated.
- the electrocatalytic activity of a catalytically redox-active unit immobilized on an electrode reduces the activation energy of the electrode reaction of the substrate to the product (energy of the most energetic state for the reaction sequence of the conversion of the substrate into the product at the electrode) and thereby leads to a shift in the for the electrode reaction of the Substrate to the product necessary electrode potential in the direction of the equilibrium potential for this electrode reaction.
- the lowering of the activation potential leads to a reduction in the overvoltage necessary for an electrode reaction and thus to an increase in the electron foot between the electrode and the substrate at a certain electrode potential suitable for the electrode reaction (this increase is generally referred to as catalytic current).
- the consequence of the electrocatalytic activity is that the electrochemical conversion of the substrate into the product can be carried out in the presence and with the participation of the catalytically redox-active unit at an electrode potential at which no or only very little current flows in the absence of the catalytically redox-active unit.
- the catalytically redox-active unit acts specifically both with regard to the substrate interacting with the catalytically redox-active unit and with regard to the reaction carried out with the respective substrate.
- redox reactions are the preferred reactions between catalytically redox-active unit and substrate.
- the term “reducing agent” denotes a chemical compound (chemical substance) which, by donating electrons to another chemical compound (chemical substance, electron donor, electron acceptor), this other chemical compound (chemical substance , Electron donor, electron acceptor) reduced.
- the reducing agent behaves analogously to an electron donor, but is used in the context of the present invention as a term for an external electron donor which does not directly belong to the redox-active unit.
- the reducing agent is either a free redox-active substance that is not bound to the nucleic acid oligomer, but is in contact with it, or that the reducing agent is covalently bound to the nucleic acid oligomer, but at a point on the nucleic acid oligomer that connects at least two covalently Nucleotides or at least two covalently linked pyrimidine or purine bases are removed from the covalent attachment site of the redox-active unit.
- the electrode can represent the reducing agent.
- the term “free redox-active substance” is used to mean a free one that is not covalently linked to the redox-active unit, the nucleic acid oligomer or the conductive surface, but with these, e.g. B. on the modified conductive surface added solution, in contact oxidizing or reducing agent called, the free redox active substance z. B. can be an uncharged molecule, any salt, an ion or a redox-active protein or enzyme (oxidoreductase).
- the free redox-active substance is characterized in that it can reduce (or oxidize) the donor (or the acceptor) of the catalytically redox-active unit.
- the specific substrate of the catalytically redox-active unit is a free, redox-active substance.
- the modified nucleic acid oligomer is bound directly or indirectly (via a spacer) to a conductive surface.
- conductive surface is understood to mean any electrically conductive surface of any thickness, in particular metallic surfaces, surfaces made of metal alloys or doped or undoped semiconductor surfaces, it being possible for all semiconductors to be used as pure substances or as mixtures.
- the conductive surface can be used alone or on any carrier material, such as, for. B. glass, applied.
- the term “electrode” is used as an alternative to “conductive surface”.
- modified conductive surface is understood to mean a conductive surface which is modified by binding a nucleic acid oligomer modified with a catalytically redox-active unit.
- functionalized electrode is used as an alternative to the term “modified conductive surface”.
- the present invention relates to a method which enables the electrochemical detection of molecular structures such as e.g. B. the detection of the substrate, but especially the electrochemical detection of DNA / RNA / PNA fragments in a sample solution by sequence-specific nucleic acid oligomer Hybridization enables.
- the detection of hybridization events by means of electrical signals is a simple and inexpensive method and enables use on site in a battery-operated variant.
- the present invention provides a readout method for the detection of molecular structures, among other things for the parallel detection of hybridization events on an oligomer chip by reading out electrical signals in a microelectrode array.
- a read-out method that can be controlled via microelectrodes is understood to mean a method in which the detection of molecular structures on a specific electrode within the electrode array functionalized with catalytically redox-active units by electrical control of this electrode, eg. B. is achieved directly or via cMOS technology.
- parallel detection of hybridization events can also be achieved either by using different catalytically redox-active units for the individual electrodes of the array when building up the different functionalized electrodes of an electrode array, or by using a continuously conductive surface to build up the functionalized electrodes and the distinguishability of molecular structures on a certain area with identical electrode structure (of a certain test site) within the overall system (of the complete oligomer chip) is achieved by using different catalytically redox-active units for the individual test sites Addition of the specific substrate can be addressed. In the latter variant, the electrochemical response of the entire oligomer chip is detected due to the continuous conductive surface, the addressing and the reading out of the electrochemical response of individual test sites is carried out by the selective addition of the substrate specific for this test site.
- the invention provides a detection method that can be controlled via microelectrodes for the parallel qualitative and quantitative detection of redox-active substances, the respective substrate of the various catalytically redox-active units of the electrodes within of an electrode array. Binding of a catalytically redox-active unit to a nucleic acid oligomer
- a prerequisite for the method according to the invention is the binding of a catalytically redox-active unit to a nucleic acid oligomer.
- the catalytically redox-active unit can, for. B. any redox-active protein / enzyme from the group of oxidases or reductases, proteins / enzymes from this group of oxidases or reductases modified by protein engineering or gene mutation or an artificially produced unit from one or more redox-active centers (electron donor or . Acceptor) or an artificially produced unit from one or more redox-active centers (electron donor or acceptor) and one or more macromolecules binding these redox-active centers.
- Examples of a catalytically redox-active unit are:
- redox active proteins / enzymes such as e.g. B. the oxidoreeductases, some of which are summarized in Table 1 below.
- the covalent attachment of the catalytically redox-active unit is preferably carried out by covalent attachment of the cofactor with subsequent reconstitution of the apoprotein to the cofactor attached to the nucleic acid oligomer.
- catalytically redox-active units redox-active proteins / enzymes
- one of the cofactors is covalently bound to the nucleic acid oligomer and the catalytically redox-active unit is completed by reconstitution with the remaining cofactors and the apoprotein.
- Table 1 Selection of some redox-active enzymes (oxidoreductases) as examples of catalytically redox-active units.
- NAD + dependent enzymes such as e.g. B. lactate dehydrogenase (LDH, EC 1.1.1.27) or alcohol dehydrogenase (ADH, EC 1.1.1.1).
- LDH lactate dehydrogenase
- ADH alcohol dehydrogenase
- the catalytically redox-active unit e.g. LDH or ADH
- the nucleic acid oligomer can be bound to the nucleic acid oligomer by (modified) NAD + directly or via a spacer (Example 3) covalently to the nucleic acid -Oligomer is bound and the NAD + -dependent enzyme is then associated with the (modified) NAD + by noncovalent interaction.
- Structure 1 Monomer of glucose oxidase (GOx).
- the apoprotein consists of ⁇ -helical and ß-sheet domains, the coenzyme flavin-adenine dinucleotide (FAD) is shown in the form of the space-filling shallot model.
- the structure of the FAD is shown in Formula 1. In its native form, the GOx is available as a homodimer.
- R 1 to R 12 are independently H or any alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl substituent.
- the catalytically redox-active unit is distinguished according to the invention in that said unit gives off electrons to an oxidizing agent which is likewise covalently bound to the nucleic acid oligomer, or accepts electrons from another reducing agent which is likewise covalently bound to the oligonucleotide, this oxidizing or reducing agent in particular one can be electrically conductive surface (electrode) and the catalytically redox-active unit, in particular the redox-active center of the unit, can be electrooxidized / reduced by applying an external voltage to this electrode in the electrochemically accessible potential range of the electrode.
- the catalytically redox-active unit is distinguished by the fact that the redox-active center of the unit (directly or after the specific reaction with the substrate) can be oxidized or reduced on an electrode and the original state of the catalytically redox-active unit - before the oxidation or reduction on the electrode - is restored in a specific catalytic reaction by the specific reaction of the catalytically redox-active unit with the associated substrate.
- any catalytically redox-active unit can be used for this as long as it or the redox-active center of the catalytically redox-active unit can be oxidized and reduced at a potential ⁇ which satisfies the condition 2.0 V> ⁇ > - 2.0 V.
- the potential here relates to the free, unmodified, redox-active center of the catalytically redox-active unit in one suitable solvent, measured against normal hydrogen electrode.
- the potential range 1.7 V> ⁇ > - 1.7 V is preferred, the range 1.4 V ⁇ ⁇ > - 1.2 V being particularly preferred and the range 0.9 V> ⁇ > - 0 , 7 V, in which the redox-active centers of the application examples are oxidized (and reduced), is very particularly preferred.
- the catalytically redox-active unit is characterized in that, by incorporating the catalytically redox-active unit in the electrochemical oxidation or reduction, the substrate specific for the redox-active center of the unit is oxidized or reduced electrocatalytically on an electrode. H. at a potential at which no or only very little current would flow in the absence of the catalytically redox-active unit, or under the formation of a catalytic (additional) current.
- a catalytically redox-active unit is covalently bound to a nucleic acid oligomer by the reaction of the nucleic acid oligomer with the catalytically redox-active unit or parts thereof (see also section “Ways of carrying out the invention”). This binding can be done in five different ways:
- a reactive group for binding formation on the nucleic acid oligomer is a free phosphoric acid, sugar-C-3-hydroxy, carboxylic acid or amine group of the oligonucleotide backbone, in particular a group at one of the two ends of the oligonucleotide backbone, used.
- the free, terminal phosphoric acid, sugar-C-3-hydroxy, carboxylic acid or amine groups have an increased reactivity and are therefore easily typical reactions such.
- the coupling group (acid, amine, alcohol, thioalcohol or aldehyde function) required for the covalent attachment of the catalytically redox-active unit is either naturally present on the catalytically redox-active unit or is obtained by chemical modification of the catalytically redox-active unit.
- the connection of the catalytically redox-active unit can take place completely or in parts of the unit with subsequent completion of the catalytically redox-active unit (see below).
- the nucleic acid oligomer is modified via a covalently linked part of the molecule (spacer) of any composition and chain length (longest continuous chain of bonded atoms), in particular chain length 1 to 14, on the oligonucleotide backbone or on a base with a reactive group , The modification is preferably carried out at one of the ends of the oligonucleotide backbone or at a terminal base.
- an alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl substituent can be used as spacer.
- the connection of the catalytically redox-active unit can take place completely or in parts of the catalytically redox-active unit with subsequent completion of the unit (see below).
- the catalytically redox-active unit e.g.
- the LDH or ADH can be bound to the nucleic acid oligomer by (modified) NAD + directly (as described here under (a)) or is covalently bound to the nucleic acid oligomer via a spacer (as described here under (b) or in Example 3) and the NAD + -dependent enzyme is then associated with the (modified) NAD + - by noncovalent interaction.
- a terminal base or a terminal nucleotide is replaced by a cofactor of the catalytically redox-active unit and the catalytically redox-active unit is completed by reconstitution with the catalytically redox-active unit freed from this cofactor (see below).
- the binding of the catalytically redox-active unit to the nucleic acid oligomer can take place in whole or in part before or after the binding of the nucleic acid oligomer to the conductive surface.
- a redox-active protein / enzyme consisting of apoprotein and cofactor (s)
- apoprotein and cofactor s
- the catalytically redox-active unit instead of the complete catalytically redox-active unit, only the apoprotein, the apoprotein and part of the cofactors or one or more cofactors can be linked and the catalytically redox-active unit is subsequently reconstituted completed with the missing parts.
- the nucleic acid oligomer can be covalently bound to any naturally occurring or modification-attached reactive group of the protein or - in the case that the redox-active protein / enzyme consists of apoprotein and Cofactor (s) exist - to any reactive group of any arbitrary cofactor that is present naturally or is attached by modification.
- the covalent attachment to any, naturally present or modification-attached, reactive group of an (arbitrary) cofactor of the protein is preferred.
- conductive surface is understood to mean any carrier with an electrically conductive surface of any thickness, in particular Surfaces made of platinum, palladium, gold, cadmium, mercury, nickel, zinc, carbon, silver, copper, iron, lead, aluminum and manganese.
- any doped or undoped semiconductor surfaces of any thickness can also be used. All semiconductors can be used as pure substances or as mixtures. As non-limiting examples, carbon, silicon, germanium, ⁇ -tin, Cu (l) - and Ag (l) - halides of any crystal structure are mentioned here. Also suitable are all binary compounds of any composition and structure from the elements of groups 14 and 16, the elements of groups 13 and 15, and the elements of groups 15 and 16. In addition, ternary compounds of any composition and structure from the elements of Groups 11, 13 and 16 or the elements of groups 12, 13 and 16 can be used. The names of the groups in the Periodic Table of the Elements refer to the 1985 IUPAC recommendation.
- a nucleic acid oligomer is linked directly or via a linker / spacer to the surface atoms or molecules of a conductive surface of the type described above. This binding can be done in three different ways:
- a) The surface is modified so that a reactive group of molecules is accessible. This can be done by direct derivatization of the surface molecules, e.g. B. done by wet chemical or electrochemical oxidation / reduction. So z. B. the surface of graphite electrodes can be provided by wet chemical oxidation with aldehyde or carboxylic acid groups. Electrochemically z. B. the possibility by reduction in the presence of aryl diazonium salts the corresponding (functionalized, that is provided with a reactive group) aryl radical or by oxidation in the presence of R'C0 2 H the (functionalized) R 'radical on the graphite Coupling the electrode surface.
- An example of the direct modification of semiconductor surfaces is the derivatization of silicon surfaces to reactive silanols, ie silicon substrates with Si-OR "groups on the surface, where R" as well as R 'represents any functionalized organic residue (e.g. alkyl, Alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl substituent).
- R represents any functionalized organic residue (e.g. alkyl, Alkenyl, alkynyl, heteroalkyl, heteroalkenyl or heteroalkynyl substituent).
- the entire surface can be modified by the covalent attachment of a reactive group of a bifunctional linker, so that on the surface a monomolecular layer of any molecules is formed which preferably contain a reactive group at the end.
- bifunctional linker means any molecule of any chain length, in particular chain lengths 2-14, with two identical (homo-bifunctional) or two different (hetero-bifunctional) reactive groups of molecules
- At least one of the reactive groups of the homo- or hetero-bifunctional linker is a photo-inducible reactive group, i. H. a group that becomes reactive only through light irradiation of a certain or any wavelength.
- This linker is applied in such a way that the photoactivatable reactive group is available on the surface after the linker has been covalently bound.
- the nucleic acid oligomers are covalently attached to the surface modified in this way, whereby they themselves are modified with a reactive group via a spacer of any composition and chain length, in particular chain length 1-14, preferably near one end of the nucleic acid oligomer.
- the reactive group of the oligonucleotide is a group which reacts directly (or indirectly) with the modified surface to form a covalent bond.
- a further reactive group can be bound to the nucleic acid oligomers in the vicinity of their second end, this reactive group, in turn, as described above, being attached directly or via a spacer of any composition and chain length, in particular chain length 1-14.
- the catalytically redox-active unit (complete or components thereof) can be attached to this second end of the nucleic acid oligomer.
- the nucleic acid oligomer to be applied to the conductive surface is modified with one or more reactive groups via a covalently attached spacer of any composition and chain length, in particular chain length 1-14, the reactive groups preferably being in the Is located near one end of the nucleic acid oligomer.
- the reactive groups are groups that can react directly with the unmodified surface.
- nucleic acid oligomers of the general formula (nx HS spacer) oligo, (nx RSS spacer) oligo or oligo spacer SS -Spacer-oligo that react with a gold surface to form gold-sulfur bonds or (ii) amines that attach to platinum or silicon surfaces through chemical or physical sorption.
- a further reactive group can be bound to the nucleic acid oligomers in the vicinity of their second end, this reactive group in turn, as described above, directly or is connected via a spacer of any composition and chain length, in particular chain length 1-14.
- the catalytically redox-active unit (complete or components thereof) can be attached to this second end of the oligonucleotide.
- nucleic acid oligomers which are modified with a plurality of spacer-bridged thiol or disulfide bridges ((nx HS spacer) oligo or (nx RSS spacer) oligo) have the advantage that such nucleic acid oligomers at a certain angle of attack against the conductive surface (angle between the surface normal and the helix axis of a double-stranded helical nucleic acid oligomer or between the surface normal and the axis perpendicular to the base pairs of a double-stranded non-helical nucleic acid oligomer) can be applied if the thiol or disulfide Functions to the nucleic acid oligomer spacer, viewed from one end of the nucleic acid, have an increasing or decreasing chain length.
- the reactive group on the probe nucleic acid oligomer is the phosphoric acid, sugar-C-3-hydroxy, carboxylic acid or amine groups of the oligonucleotide backbone, in particular terminal groups.
- the phosphoric acid, sugar-C-3-hydroxy, carboxylic acid or amine groups have an increased reactivity and are therefore easy to carry out typical reactions such.
- the coupling group required for covalent attachment to the phosphoric acid, sugar-C-3-hydroxy, carboxylic acid or amine group is part of the surface derivatization with a (monomolecular) layer of any molecular length, as under a) in described in this section, or the phosphoric acid, sugar-C-3-hydroxy, carboxylic acid or amine group can react directly with the unmodified surface, as described under b) in this section.
- a further reactive group can be bound to the oligonucleotides near their second end, this reactive group, in turn, as described above, being attached directly or via a spacer of any composition and chain length, in particular chain length 1-14.
- the catalytically redox-active unit (complete or components thereof) can be attached to this second end of the nucleic acid oligomer.
- the nucleic acid oligomer can be bound to the conductive surface before or after the catalytically redox-active unit has been bound to the nucleic acid oligomer.
- a redox-active protein / enzyme consisting of apoprotein and cofactor (s)
- the complete catalytically redox-active unit instead of the complete catalytically redox-active unit, only the apoprotein, the apoprotein with some of the cofactors or one or more of the cofactors can be linked, and the catalytically redox-active unit is obtained by subsequent reconstitution completed with the missing parts.
- the electron-acceptor (or donor), as under b) or c) in the section "Binding a catalytically redox-active unit a nucleic acid oligomer " be bound to or instead of a terminal base on the nucleic acid oligomer and the electron donor (or acceptor) is bound by subsequent covalent attachment to a reactive group of the electron acceptor (or donor) are or, as described under a) in the section "Binding a catalytically redox-active unit to a nucleic acid oligomer", by subsequent attachment to a terminal reactive group of the nucleic acid oligomer backbone at the same end (see also the section "Ways of carrying out the Invention").
- the nucleic acid oligomer can be bound to the conductive surface before or after the spacer provided with a reactive group is bound to bind the catalytically redox-active unit.
- the binding of the already modified nucleic acid oligomer to the conductive surface ie the binding to the surface after the connection of the catalytically redox-active unit to the nucleic acid oligomer or after the connection of parts of the catalytically redox-active unit or after the connection with a reactive group provided spacers for binding the catalytically redox-active unit is also carried out as described under a) to c) in this section.
- the monofunctional linker has a chain length which is identical to the chain length of the spacer between the surface and the nucleic acid oligomer or which deviates by a maximum of four chain atoms.
- the nucleic acid-oligomer double strand is thermally dehybridized after the double stranded nucleic acid oligomer and the linker have been bonded to the surface.
- the simultaneous attachment of a linker to the surface increases the distance between the single-stranded or double-stranded nucleic acid oligomers likewise bound to the surface. If double-stranded nucleic acid oligomer is used, this effect is further enhanced by the subsequent thermal dehybridization.
- oligomer (DNA) chip to complete the sequence to detect any target nucleic acid oligomer or a (fragmented) target DNA or to detect mutations in the target and detect them in a sequence-specific manner or to detect the presence of known genes or known nucleic acid oligomers.
- an array of microelectrodes is used, which either consists of electrodes that are individually and directly connected to a current / voltage source, or an electrode array is applied by microstructuring on a common surface, in which the individual electrodes are controlled using cMOS technology and can be read out.
- the surface atoms or molecules are linked with DNA / RNA / PNA nucleic acid oligomers of known but any sequence, as described above.
- a single electrode can also be derivatized with a single probe oligonucleotide or a unique type of probe oligonucleotide (with the same base sequence and with the same catalytically redox-active unit).
- Nucleic acid oligomers eg DNA, RNA or PNA fragments
- a catalytically redox-active unit is or is bound to the probe nucleic acid oligomers, as described below.
- parallel detection of hybridization events can also be achieved either by using different catalytically redox-active units for the individual electrodes of the array when building up the different functionalized electrodes of an electrode array, or by using a continuously conductive surface to build up the functionalized electrodes and the distinguishability of molecular structures on a certain area with identical electrode structure (of a certain test site) within the overall system (of the complete oligomer chip) is achieved by using different catalytically redox-active units for the individual test sites Addition of the specific substrate can be addressed. The latter variant is due to the continuous conductive surface, the electrochemical response of the entire oligomer chip is detected, the addressing and reading of the electrochemical response of individual test sites is carried out by the selective addition of the substrate specific for this test site.
- the modification of the probe nucleic acid oligomers with a catalytically redox-active unit can take place completely or in components of the catalytically redox-active unit either before or after the binding of the probe oligonucleotide to the conductive surface.
- the various possible combinations of the individual steps (reaction sequences) are demonstrated with the aid of FIG. 2 using the example of a catalytically redox-active unit bound to an electrode via a probe oligonucleotide in the section “Ways of carrying out the invention”.
- a surface hybrid of the general structure elek-spacer-ss-oligo-spacer unit is formed, "unit" being representative of the catalytically redox-active unit.
- the bridges can of course also be carried out without a spacer or with only one spacer (Elek-ss-oligo-spacer unit or Elek-Spacer-ss-oligo unit).
- the unit is glucose oxidase (GOx), a redox-active enzyme consisting of apoprotein and cofactor.
- GOx glucose oxidase
- the GOx is covalently linked to the nucleic acid oligomer via its cofactor flavin-adenine dinucleotide (FAD) in the so-called FAD-protein binding pocket of the GOx.
- FAD cofactor flavin-adenine dinucleotide
- the GOx forms a 1: 1 complex with the cofactor FAD, the GOx occurring in its natural form as a homodimer, but also having a catalytic activity in the form of a monomer relevant to the invention.
- the unit is lactate dehydrogenase, an NAD + -dependent enzyme which, by noncovalent interaction, associates with the (modified) NAD + covalently bound to the probe oligonucleotide.
- the electrochemical communication between the (conductive) surface and the catalytically redox-active unit (“unit”) bridged by a single-strand oligonucleotide in the general structure elek-spacer-ss-oligo-spacer unit is weak or nonexistent.
- the test sites are brought into contact with the nucleic acid oligomer solution (target) to be examined.
- Hybridization only occurs in the case in which the solution contains nucleic acid-oligomer strands which are complementary to the probe-nucleic acid oligomers bound to the conductive surface, or at least are complementary in a wide range.
- Hybridization between probe and target nucleic acid oligomer leads to an increased conductivity between the surface and the catalytically redox-active unit, since this is now bridged by the double-stranded nucleic acid oligomer.
- Figure 3 shows this schematically using the example of the Elek-Spacer-ss-oligo-Spacer-FAD (GOx).
- FIG. 4 shows the sequence of the electron transfer steps in Elek-Spacer-ds-oligo-Spacer-FAD (GOx) in detail
- FIG. 5 shows the example of Elek-Spacer-ss-oligo-Spacer-PQQ-NAD + -LDH schematically shows
- Figure 6 shows the sequence of the electron transfer steps in Elek-Spacer-ds-oligo-NAD + - LDH in detail.
- a sequence specific hybridization event can be carried out by electrochemical methods such as e.g. B. cyclovoltametry, amperometry, potentiometry or conductivity measurements can be detected.
- the potential of a stationary working electrode is changed linearly as a function of time. Starting from a potential at which there is no electrooxidation or reduction, the potential is changed until the redox-active substance is oxidized or reduced (i.e. current flows). After passing through the oxidation or reduction process, which in the current / voltage curve generates an initially rising current, then a maximum current (peak) and finally a gradually decreasing current, the direction of the potential feed is reversed. The behavior of the products of electrooxidation or reduction is then recorded in the return.
- catalytically redox-active unit can be electro-oxidized (electroreduced) by applying a suitable, constantly kept electrode potential, but the re-reduction (reoxidation) of the catalytically redox-active unit to the original state is not as in the cyclic voltammetry takes place by changing the electrode potential, but by means of a suitable reducing agent (oxidizing agent), the "redox-active substance" added to the target solution, whereby the circuit of the entire system is closed.
- a suitable reducing agent oxidizing agent
- the flavin adenine dinucleotide (FAD) cofactor of the enzyme is covalently bound to the probe oligonucleotide and then reconstituted with the glucose oxidase apoprotein (GOx).
- the resulting surface hybrid of the general structure Elek-Spacer-ss-oligo-Spacer-FAD (GOx) has little or no conductivity between the electrode and the FAD. In the case of hybridization with the target oligonucleotide complementary to "ss-oligo", the conductivity is increased significantly.
- the FAD of gucose oxidase (FAD (GOx)) is reduced to FADH 2 of glucose oxidase (FADH 2 (GOx)), whereby glucose is oxidized to gluconic acid.
- FIG. 1 shows a schematic representation of oligonucleotide sequencing by hybridization on a chip
- Fig. 2 Different reaction sequences for the production of the surface hybrid Elek-Spacer-ss-oligo-Spacer-PQQ-FAD (GOx).
- the catalytically redox-active unit in this surface hybrid is glucose oxidase (GOx) consisting of apoprotein and flavin adenine dinucleotide (FAD) cofactor.
- the GOx is covalently linked to the oligonucleotide via its cofactor FAD via PQQ and a spacer;
- FIG. 3 shows a schematic representation of the amperometric measurement method using the example of the surface hybrid elek-spacer-ss-oligo-spacer-PQQ-FAD (GOx) from FIG. 2 (injection: addition (injection) of the substrate glucose);
- the apx protein of the GOx is only indicated as a shell (solid line) (see structure 1).
- the 12 bp probe oligonucleotide of the exemplary sequence 5'-TAGTCGGAAGCA-3 ' is shown as a section in the hybridized state;
- FIG. 5 shows a schematic representation of the amperometric measurement method using the example of the surface hybrid Elek-Spacer-ss-oligo-Spacer-PQQ-NAD + -LDH (Inj .: addition (injection) of the substrate lactate);
- the 12 bp probe oligonucleotide of the exemplary sequence 5'-TAGTCGGAAGCA-3 ' is shown as a section in the hybridized state;
- a formation unit of an exemplary test site with hybridized target, Au-S (CH 2 ) 2 -ds-oligo-spacer-PQQ-FAD (GOx) of the general structure elek-spacer-ds-oligo-spacer unit is shown in FIG. 4 shown.
- formation unit is understood to mean the smallest repeating unit of a test site or of a functionalized electrode within the electrode array.
- the surface is a gold electrode.
- the connection between gold electrode and probe oligonucleotide was established with the linker (HO- (CH 2 ) 2 -S) 2 , which with the terminal phosphate group at the 3 'end to P-0- (CH 2 ) 2 -SS- (CH 2 ) 2 -OH was esterified and after homolytic cleavage of the SS bond on the gold surface each caused an Au-S bond, with which 2-hydroxy-mercaptoethanol and mercaptoethanol-bridged oligonucleotide was co-adsorbed on the surface.
- the catalytically redox-active unit in the example in FIG. 4 is glucose oxidase (GOx), a redox-active enzyme consisting of apoprotein and FAD cofactor (s).
- the modification of the probe oligonucleotides with the complete or with a component of the catalytically redox-active unit can take place either before or after the binding of the probe oligonucleotide to the conductive surface.
- the various possible combinations of the individual steps, which in principle lead to the same educational unit of a test site or one Functionalized electrode within the electrode array, should be shown below with the help of Figure 2 using the example of the surface hybrid Au-S (CH 2 ) 2 -ss-oligo-spacer-PQQ-FAD (GOx) or in its more general form as Elek -Spacer-ss- oligo-Spacer-PQQ-FAD (GOx) are shown.
- the GOx can be freed from the FAD cofactor by simple manipulation (see Example 4), so that GOx can be broken down into two components, FAD and apoprotein.
- the probe oligonucleotide is provided with (identical or different) reactive groups in the vicinity of the two ends via an (arbitrary) spacer.
- the probe oligonucleotide modified in this way can covalently bind together with the monofunctional linker in the presence of a monofunctional linker (corresponding to points a) - c) and 2.) in the section "Binding an oligonucleotide to the conductive surface” the electrode is connected, taking care that enough monofunctional linker of suitable chain length is added in order to provide sufficient space between the individual probe oligonucleotides for hybridization with the target oligonucleotide and for the connection of the catalytically redox-active unit.
- the free, spacer-bridged, reactive group of the probe oligonucleotide PQQ and then N 6 - (2-aminoethyl) -FAD (formula 5 or example 1) are bound to it.
- the binding is carried out as described under a) or b) in the section “Binding a catalytically redox-active unit to a nucleic acid oligomer” or in Example 4.
- the apoprotein of GOx is then reconstituted on the (modified) FAD cofactor as described in Example 9.
- reaction sequence "2" the probe oligonucleotide (modified with spacers and reactive groups) can first be covalently bound to the electrode without a free, monofunctional linker (spacer), resulting in a flat attachment of the oligonucleotide. The free, monofunctional linker (spacer) is then covalently bound to the electrode.
- reaction sequence "3" consists in first modifying the probe oligonucleotide (with spacers and reactive groups) with PQQ and FAD, then covalently binding it to the electrode in the presence of free, monofunctional linker (spacer) and then to reconstitute with the GOx apoprotein.
- the probe oligonucleotide (modified with spacers and reactive groups) can first be modified with PQQ and FAD, in order to then reconstitute it with the GOx apoprotein and then covalently bind it to the electrode. If, as in the case of the GOx, the catalytically redox-active unit has a substantially larger diameter than the hybridized ds-oligonucleotide (larger than 30 A), the covalent attachment of a suitable free, monofunctional linker (spacer) to the electrode can be dispensed with.
- the GOx can be freed from the FAD cofactor by simple manipulation (see Example 4), so that GOx can be broken down into two components, FAD and apoprotein.
- the probe oligonucleotide is provided with (identical or different) reactive groups in the vicinity of the two ends via an (arbitrary) spacer.
- the probe oligonucleotide modified in this way can covalently attach to the monofunctional linker in the presence of a monofunctional linker (corresponding to points a) - c) and 2.) in the section "Binding an oligonucleotide to the conductive surface") the electrode is connected, taking care that enough monofunctional linker of suitable chain length is added in order to provide sufficient space between the individual probe oligonucleotides for hybridization with the target oligonucleotide and for the connection of the catalytically redox-active unit.
- the free, spacer-bridged, reactive group of the probe oligonucleotide PQQ and then N 6 - (2-aminoethyl) -FAD (formula 5 or example 1) are bound to it.
- the binding is carried out as described under a) or b) in the section “Binding a catalytically redox-active unit to a nucleic acid oligomer” or in Example 4.
- the apoprotein of GOx is then reconstituted on the (modified) FAD cofactor as described in Example 9.
- the probe oligonucleotide (modified with spacers and reactive groups) can first be covalently bound to the electrode without a free, monofunctional linker (spacer), resulting in a flat attachment of the oligonucleotide.
- the free, monofunctional linker (spacer) is then covalently bound to the electrode.
- Another possibility (reaction sequence "3") is to first modify the probe oligonucleotide (with spacers and reactive groups) using PQQ and FAD, then covalently attach it to the electrode in the presence of free, monofunctional linker (spacer) and then to reconstitute with the GOx apoprotein.
- the probe oligonucleotide (modified with spacers and reactive groups) can first be modified with PQQ and FAD, in order to then reconstitute it with the GOx apoprotein and then covalently bind it to the electrode. If, as in the case of the GOx, the catalytically redox-active unit has a substantially larger diameter than the hybridized ds-oligonucleotide (larger than 30 A), the covalent attachment of a suitable free, monofunctional linker (spacer) to the electrode can be dispensed with. otherwise it happens Detect amperometry.
- the individual electron transfer steps which are triggered by the substrate in the surface hybrid Au-S (CH 2 ) 2 -ds-oligo-spacer-PQQ-FAD (GOx) are shown in FIG. 4.
- the surface hybrid Au-S (CH 2 ) 2 -ds-oligo-spacer-PQQ-FAD (GOx) can also be reversed under suitable external circumstances, so that FAD is reduced by the electrode and reduced FAD (FAD ⁇ or FAD 2- or FADH 2 ) is oxidized by a suitable substrate in a catalytic reaction.
- FIG. 5 Another test site or another functionalized electrode within the electrode array, Au-S (CH 2 ) 2 -ds-oligo-spacer-PQQ-NAD + -LDH, of the general structure Elek-Spacer-ss-oligo- Spacer unit is shown in Figure 5.
- ADH substrate lactate By adding the ADH substrate lactate, electrons are transferred to the FMN cofactor of the LDH and from this reduced FMN (FMN- or FMN 2 or FMNH 2 ) directly or with the participation of other cofactors of the LDH to NAD + and finally from reduced NAD + (NAD, NAD- or NADH) can be transferred to the electrode.
- the surface hybrid Au-S (CH 2 ) 2 -ds-oligo-spacer-PQQ-NAD + " -LDH can also be reversed under suitable external circumstances, so that NAD + is reduced by the electrode and reduced NAD + (NAD " NAD " or NADH) is oxidized by a suitable substrate (e.g. acetaldehyde) in a catalytic reaction.
- a suitable substrate e.g. acetaldehyde
- test sites nucleic acid-oligomer combinations
- a specific test site or a specific test site group can be easily applied can be addressed and added by amperometric detection by adding the respective specific substrates.
- the various test sites therefore do not have to be applied to individual (micro) electrodes which are electrically insulated from one another and can be individually controlled to apply a potential and read out the current.
- faulty base pairings can be recognized by a changed cyclic voltammetric characteristic.
- a mismatch manifests itself in a larger potential distance between the current maxima of the electroreduction and the electroreoxidation (reversal of the electroreduction with reversed direction of potential feed) or the electrooxidation and electroreduction in a cyclovoltammetrically reversible electron transfer between the electrically conductive surface and the catalytically redox-active unit. This fact has a particularly favorable effect in amperometric detection, since the current can be tested there at a potential at which the perfectly hybridizing oligonucleotide target delivers significant current, but not the incorrectly paired oligonucleotide target.
- Example 1 Modification of the FAD to the frf- ⁇ -aminoethyl -FAD, formula 5, or of the NAD * to the f- ⁇ -aminoethyO-NAD * :
- N 6 - (2-aminoethyl) -NAD + can also be prepared under the same reaction conditions if NAD + is used as the starting substance instead of FAD.
- Example 2 Production of the oligonucleotide electrode Au-S-fCH ⁇ ss-oligo-spacer-PQQ-FAD (GOx): The production of Au-S- (CH 2 ) 2 -ss-oligo-spacer-PQQ-FAD (GOx) is divided into 5 sections, namely the representation of the conductive surface, the derivatization of the surface with the probe oligonucleotide in the presence of a suitable monofunctional linker (incubation step), the covalent attachment Test site groups) can be used.
- test sites nucleic acid-oligomer combinations
- a specific test site or a specific test site group can be easily applied can be addressed and added by amperometric detection by adding the respective specific substrates.
- the various test sites therefore do not have to be applied to individual (micro) electrodes which are electrically insulated from one another and can be individually controlled to apply a potential and read out the current.
- faulty base pairings can be recognized by a changed cyclic voltammetric characteristic.
- a mismatch manifests itself in a larger potential distance between the current maxima of the electroreduction and the electroreoxidation (reversal of the electroreduction with reversed direction of potential feed) or the electrooxidation and electroreduction in a cyclovoltammetrically reversible electron transfer between the electrically conductive surface and the catalytically redox-active unit. This fact has a particularly favorable effect in amperometric detection, since the current can be tested there at a potential at which the perfectly hybridizing oligonucleotide target delivers significant current, but not the incorrectly paired oligonucleotide target.
- N 6 - (2-aminoethyl) -NAD + can also be prepared under the same reaction conditions if NAD + is used as the starting substance instead of FAD.
- Example 2 Preparation of the oligonucleotide electrode FAD (GOx): The production of Au-S-fCH ⁇ ss-oligo-spacer-PQQ-FADfGOx) is divided into 5 sections, namely the representation of the conductive surface, the derivatization of the surface with the probe oligonucleotide in the presence of a suitable one monofunctional linker (incubation step), the covalent linkage the PQQ (redox step I), the binding of the N 6 - (2-aminoethyl) -FAD (redox step II) and the reconstitution of the apoprotein the GOx (reconstitution step).
- FAD GOx
- the carrier material for the covalent attachment of the double-stranded oligonucleotides is formed by an approximately 100 nm thin gold film on mica (muscovite platelet).
- mica muscovite platelet
- gold (99.99%) was applied in a layer thickness of approx. 100 nm by electrical discharge.
- the gold film was then freed from surface impurities (oxidation of organic deposits) with 30% H 2 0 2 , / 70% H 2 S0 4 and immersed in ethanol for about 20 minutes in order to displace oxygen adsorbed on the surface.
- a double-modified 12 bp single-stranded oligonucleotide of the sequence 5'-TAGTCGGAAGCA-3 ' was used, which at the phosphate group of the 3' end with (HO- (CH 2 ) 2 -S) 2 to P-0- (CH 2 ) 2 -SS- (CH 2 ) 2 -OH is esterified.
- the gold electrode modified with a monolayer of ss-oligonucleotide and 2-hydroxy-mercaptoethanol was washed with bidistilled water and then with a solution of 3x10 3 molar quinone PQQ, 10 "2 molar EDC and 10 " 2 molar sulfo-NHS in HEPES buffer wetted.
- the -CH CH-CO-NH-CH 2 -CH 2 -NH 2 spacer and the PQQ form a covalent bond (amide formation between the amino group of the spacer and the C-7 carboxylic acid function of the PQQ, redox step I).
- the gold electrode modified in this way was then washed with bidistilled water and with a solution of 1-10 x 10 "3 molar quinone N 6 - (2-aminoethyl) - FAD, 1-5 x 10 " 2 molar EDC and 10 "2 molar sulfo -NHS wetted in HEPES buffer After a reaction time of about 1-4 h, PQQ and the N 6 - (2-aminoethyl) -FAD form a covalent bond (amide formation between the amino group of the spacer and the C-2-carboxylic acid function of the the oligonucleotide-bound PQQ, redox step II)
- Example 3 Preparation of the oligonucleotide electrode Au-S- (CH ⁇ 2 -ss-oligo-spacer-PQQ NAD * LDH: The production of Au-S- (CH 2) 2 -ss-oligo-spacer-PQQ -NAD + -LDH is divided into 5 sections, namely the representation of the conductive surface, the derivatization of the surface with the probe oligonucleotide in the presence of a suitable monofunctional linker (incubation step), the covalent attachment of the PQQ (redox step I), the attachment of the N 6 - (2-Aminoethyl) -NAD + (redox step II) and the association with LDH (association step).
- the carrier material for the covalent attachment of the double-stranded oligonucleotides is formed by an approximately 100 nm thin gold film on mica (muscovite platelet).
- mica muscovite platelet
- gold (99.99%) was applied in a layer thickness of approx. 100 nm by electrical discharge.
- the gold film was then freed from surface impurities (oxidation of organic deposits) with 30% H 2 0 2 , / 70% H 2 S0 4 and immersed in ethanol for about 20 minutes in order to displace oxygen adsorbed on the surface.
- a double-modified 12 bp single-strand oligonucleotide of the sequence 5'-TAGTCGGAAGCA-3 ' was used for the incubation, which was attached to the phosphate group of the 3' end is esterified with (HO- (CH 2 ) 2 -S) 2 to give P-0- (CH 2 ) 2 -SS- (CH 2 ) 2 -OH.
- the spacer forms a covalent Au-S bond with the Au atoms on the surface, which leads to a 1: 1 coadsorption of the SS oligonucleotide and the split off 2-hydroxy-mercaptoethanol.
- the free 2-hydroxy-mercaptoethanol which is simultaneously present in the incubation solution is also adsorbed by forming an Au-S bond (incubation step).
- the gold electrode modified in this way was then washed with bidistilled water and with a solution of 1-10 x 10 "3 molar quinone N 6 - (2-aminoethyl) - NAD + , 1-5 x 10 " 2 molar EDC and 10 "2 molar sulfo-NHS wetted in HEPES buffer After a reaction time of about 1 to 4 h, PQQ and the N 6 - (2-aminoethyl) -NAD + form a covalent bond (amide formation between the amino group of the spacer and the C-2-carboxylic acid function of the PQQ bound to the oligonucleotide, redox step II)
- the protein peak is eluted at a flow rate of 1.3 mUmin and collected in a storage container with 0.4 molar phosphate buffer (4 ml with the addition of 200 mg bovine serum albumin and 400 mg activated carbon) (the protein peak can be recognized by UV absorption of the eluate) ,
- 10% sodium azide in water (w / v) is added until the total concentration of sodium azide is 0.1% (w / v).
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19945398A DE19945398A1 (de) | 1999-09-22 | 1999-09-22 | Elektrochemische Detektion von sequenzspezifischen Nukleinsäure-Oligomer-Hybridisierungsereignissen |
DE19945398 | 1999-09-22 | ||
PCT/DE2000/003016 WO2001021635A2 (de) | 1999-09-22 | 2000-09-01 | Elektrochemische detektion von sequenzspezifischen nukleinsäure-oligomer-hybridisierungsereignissen |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1228081A1 true EP1228081A1 (de) | 2002-08-07 |
Family
ID=7922897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00972570A Withdrawn EP1228081A1 (de) | 1999-09-22 | 2000-09-01 | Elektrochemische detektion von sequenzspezifischen nukleinsäure-oligomer-hybridisierungsereignissen |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1228081A1 (de) |
AU (1) | AU1128501A (de) |
DE (1) | DE19945398A1 (de) |
WO (1) | WO2001021635A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6649350B2 (en) * | 1997-04-09 | 2003-11-18 | California Institute Of Technology | Electrochemical sensor using intercalative, redox-active moieties |
DE10013254A1 (de) | 2000-03-17 | 2001-10-04 | Friz Biochem Gmbh | Vorrichtung und Verfahren zum Nachweis organischer Moleküle in einer Probensubstanz |
DE10049527A1 (de) * | 2000-10-06 | 2001-09-06 | Friz Biochem Gmbh | Thermostabile,photoinduzierbar redoxaktive Einheit zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen |
DE102005007148B4 (de) * | 2005-02-11 | 2008-05-15 | Universität Rostock | Verfahren und Array zur Replizierung und Analytik von Nukleinsäuren |
EP2105146A1 (de) * | 2007-11-07 | 2009-09-30 | Riken | Nukleinsäure-vermittelte Freisetzung von Substanzen |
DE102013000682B3 (de) * | 2013-01-08 | 2013-10-31 | Rainer Hintsche | Verfahren zur Detektion von Molekülen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824473A (en) * | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
CA2270633A1 (en) * | 1996-11-05 | 1998-05-14 | Clinical Micro Sensors | Electrodes linked via conductive oligomers to nucleic acids |
US6221586B1 (en) * | 1997-04-09 | 2001-04-24 | California Institute Of Technology | Electrochemical sensor using intercalative, redox-active moieties |
DE19964220C2 (de) * | 1998-11-23 | 2003-07-03 | Friz Biochem Gmbh | Verfahren zur Herstellung einer modifizierten leitfähigen Oberfläche |
DE19901761A1 (de) * | 1999-01-18 | 1999-07-01 | Gerhard Dr Hartwich | Verfahren zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen |
-
1999
- 1999-09-22 DE DE19945398A patent/DE19945398A1/de not_active Withdrawn
-
2000
- 2000-09-01 EP EP00972570A patent/EP1228081A1/de not_active Withdrawn
- 2000-09-01 AU AU11285/01A patent/AU1128501A/en not_active Abandoned
- 2000-09-01 WO PCT/DE2000/003016 patent/WO2001021635A2/de not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO0121635A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001021635A2 (de) | 2001-03-29 |
DE19945398A1 (de) | 2001-04-05 |
WO2001021635A3 (de) | 2001-05-17 |
AU1128501A (en) | 2001-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19964220C2 (de) | Verfahren zur Herstellung einer modifizierten leitfähigen Oberfläche | |
EP1144685B1 (de) | Verfahren zur elektrochemischen detektion von nukleinsäure -oligomer- hybridisierungsereignissen | |
DE69932236T2 (de) | Elektrochemischer sensor unter verwendung von interkalativen, redox-aktiven teilen | |
DE19926457A1 (de) | Verfahren zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen | |
DE60216626T2 (de) | Amperometrischer sensor | |
EP1554396B1 (de) | Verdrängungsassay zur detektion von nukleinsäureoligomer-hybridisierungsereignissen | |
DE102005039726B3 (de) | Verfahren zur Markierung und Analyse von Nukleinsäuren | |
EP1228081A1 (de) | Elektrochemische detektion von sequenzspezifischen nukleinsäure-oligomer-hybridisierungsereignissen | |
DE19921940C2 (de) | Verfahren zur elektrochemischen Detektion von Nukleinsäureoligomerhybriden | |
WO2011069501A1 (de) | Kompetitionsassay zur detektion von nukleinsäureoligomer-hybridisierungsereignissen | |
DE102011056606B3 (de) | Verfahren zur elektrochemischen Detektion von Nukleinsäureoligomer-Hybridisierungsereignissen | |
DE10049527A1 (de) | Thermostabile,photoinduzierbar redoxaktive Einheit zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen | |
WO2003018834A2 (de) | Verdrängungsassay zur detektion von nukleinsäureoligomer-hybridisierungsereignissen | |
DE10221091B4 (de) | SECM zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen | |
DE10221004A1 (de) | Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen unter Verwendung im wesentlichen ungeladener Ligat-Oligonukleotide | |
DE10212958A1 (de) | Verfahren zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen | |
MXPA01003985A (en) | Method for the electrochemical detection of nucleic acid oligomer hybrids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020116 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20030902 |
|
19U | Interruption of proceedings before grant |
Effective date: 20040201 |
|
19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20040927 |
|
19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20050228 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040113 |